Resource Guide: Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri exposure

A curated reading list of authoritative medical research, drug-safety databases, and focused analysis for researchers, patients, and advocates.

In-depth resource

Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri exposure

A focused review of background, context, and source material on this subject.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

PubMed Central (PMC)

Reference: PubMed Central (PMC)

Authoritative source for clinical, regulatory, and public-health background reading.